|
There has been a time change.
Annex Hall 1 |
Annex Hall 2 |
|
8:50 |
Opening remarks (Organiser of KBCCC 2009 International Convention) |
|
9:00 |
Session 1: Axillary diagnosis and treatment Moderators: Klimberg S. (Arkansas, USA), Roukos D. H. (Ioannina, Greece) |
|
9:00 |
Axillary reverse mapping - a new technique to prevent lymphedema after axillary lymphadenectomy Klimberg S. (Arkansas, USA) |
|
9:40 |
Current status of sentinel lymph node biopsy in Japan Nakamura S. (Tokyo, Japan) |
|
10:00 |
Sentinel lymph node biopsy in DCIS and large invasive breast cancer the role of breast ultrasound Huang C. S. (Taipei, Taiwan) |
|
10:20 |
Surgical treatment of axillary node after neo-adjuvant chemotherapy in patients with locally advanced breast cancer Lee E. S. (Seoul, Korea) |
|
10:40 |
Break |
|
10:55 |
Biooptical aspects in indocyanine green fluorescence guided sentinel node biopsy for early breast cancer Kitai T. (Nara, Japan) |
|
11:15 |
Questionnaires and Discussion Sugie T. (Kyoto, Japan) Panelists: Golshan M. (Boston, USA), Chow L. (HK, China) Discussants: Kinoshita T. (Tokyo, Japan), Jinno H. (Tokyo, Japan) |
|
12:00 |
Luncheon Seminar Chair: Kuroi K. (Tokyo, Japan) |
|
12:40 |
Poster Discussion |
|
13:00 |
Session 2: Radiation therapy (sponsored by Pfizer Japan Inc.) Moderators: Strom E. A. (Houston, USA), Mitsumori M. (Kyoto, Japan) | |
13:00 |
Role of radiation therapy in breast cancer Arriagada R. (Paris, France: Stockholm, Sweden) |
|
13:40 |
Breast cancer irradiation after initial chemotherapy Strom E. A. (Houston, USA) |
|
14:20 |
Current Pattern of Care in RT in Korea Ha S.W. (Seoul, Korea) |
|
14:35 |
Current status of breast cancer radiotherapy in China – regarding several controversial issues Chen J. (Shanghai, China) |
|
14:50 |
Current Patterns of Care for localized breast cancer in Japan: Results from 2003-2005 national survey Mitsumori M. (Kyoto, Japan) |
|
15:05 |
Questionnaires and Discussion Panelists: Chen J. (Shanghai, China), Ha S.W. (Seoul, Korea), Kunkler I. (Edinburgh, UK) |
|
15:50 |
Break |
|
16:00 |
Session 3: Hormone therapy individualization (sponsored by AstraZeneca PLC) Moderators: Robertson J. F. R. (Nottingham, UK), Forbes J. (Newcastle, Australia), Toi M. (Kyoto, Japan) |
|
16:00 |
Adjuvant therapy for endocrine-responsive premenopausal patients Jakesz R. (Vienna, Austria) |
|
16:40 |
Neoadjuvant and presurgical endocrine therapy Robertson J. F. R. (Nottingham, UK) |
|
17:20 |
Update of the surrogate markers of endocrine therapy in estrogen receptor breast carcinoma Sasano H. (Sendai, Japan) |
|
17:40 |
Break |
|
17:45- |
Discussion and Case-study Panelist: Lee-E.S. (Seoul, Korea) Discussant: Imoto S. (Tokyo, Japan) |
Annex Hall 1 |
Room 104 |
|
8:00 |
Morning Seminar (sponsored by Novartis Pharma K.K.) γδT cells and zoledronate: Application to cancer immunotherapy Tanaka Y. (Kyoto, Japan) Bisphosphonate and breast cancer treatment Kohno N. (Tokyo, Japan) Chair: Kurebayashi J. (Kurashiki, Japan) |
|
8:40 |
Break |
|
9:00 |
Session 4: Local management in the era of molecular-targeting therapy (sponsored by Pfizer Japan Inc.) |
Session 5: Pathology and Biomarker Moderators: Sasano H. (Sendai, Japan), Apple S. (LA, USA) |
9:00 |
The first report of the association between the recurrence score and risk of recurrence in Japanese population T.B.A. |
(9:00) |
9:20 |
Discovery of autoantibodies in breast cancer (tentative) Chair: Saeki T. (Saitama, Japan) |
(9:20) |
9:40 |
Novel therapies for HER2+ breast cancer Krop I. E. (Boston, USA) Chair: Noh D. Y. (Seoul, Korea) |
|
|
(10:00) |
|
10:10 |
Break |
|
10:30 |
Preoperative treatment of HER2+ breast cancer Winer E. P. (Boston, USA) Chair: Inaji H. (Osaka, Japan) |
|
|
(10:40) |
|
11:10 |
Integrating standard and genetics-personal genomics data into surgery-guided algorithm and causal network models towards personalized breast cancer treatment Roukos D. H. (Ioannina, Greece) Chair: Inaji H. (Osaka, Japan) |
|
|
(11:20) |
|
11:50 |
Break |
|
12:00 |
Luncheon Seminar (sponsored by sanofi-aventis K.K.) Chair: Ohno S. (Fukuoka, Japan) |
|
13:00 |
Case-study: Preoperative systemic therapy and local management Moderators: Von Minckwitz G. (Frankfurt, Germany), Toi M. (Kyoto, Japan) Panelists: Winer E.P. (Boston, USA), Klimberg S.(Arkansas, USA) , Iwata H. (Nagoya, Japan), Han S. (Seoul, Korea) Breast conserving surgery after neoadjuvant chemotherapy Takei H. (Saitama, Japan) Neoadjuvant chemotherapy and preoperative systemic therapy |
|
14:15 |
Session 6: Optimal breast surgery Moderators: Noguchi S. (Osaka, Japan), Chow L. (HK, China), Golshan M. (Boston, USA) |
|
14:15 |
The significance of local recurrence following breast conservation treatment Benson J. R. (Cambridge, UK) |
|
14:55 |
Ductal carcinoma in situ (DCIS) axillary staging and local management Golshan M. (Boston, USA) |
|
15:35 |
Optimal surgery for breast cancer what is old? What is new? Shafir M. (NY, USA) Chair: Chen S.C. (Taipei, Taiwan) |
|
16:15 |
Break |
|
16:30 |
What is optimal local disease control in breast-conserving therapy? Iwase T. (Tokyo, Japan) |
|
16:50 |
Questionnaires and Discussion Inamoto T. (Kyoto, Japan) Panelist: Akashi-Tanaka S. (Tokyo, Japan) Discussant: Kawabata H. (Tokyo, Japan) |
|
17:40 |
Break |
|
17:50- |
Evening Seminar (sponsored by CHUGAI PHARMACEUTICAL CO., LTD.) New molecular-targeting agents Pegram M. (Miami, USA) Chair: Ikeda T. (Tokyo, Japan) |
| Annex Hall | |
8:00 |
Morning Seminar (sponsored by Hamamatsu Photonics K.K. and IMI Co., Ltd.) ICG fluorescence navigation story -application to breast cancer surgery- Miwa M. (Hamamatsu, Japan), Yamagami K. (Kobe, Japan) Chair: Kitai T. (Nara, Japan) |
8:40 |
Break |
8:50 |
Keynote Lecture Chair: Sonoo H. (Kurashiki, Japan) |
9:30 |
Consensus session 1: Issues in local management ALL |
11:20 |
Break |
11:40 |
Awards presentation for poster presenters |
11:50 |
Consensus session 2: Interaction with systemic therapy ALL |
13:15- |
Closing remarks |
19:30 Evening Reception Grand Prince Hotel Kyoto (Prince Hall)
